Participants
| Role | Name | HCID | Charge |
|---|
| Reactant | Propanal | HCID 527 | — |
| Reactant | Ethyl cyanoacetate | HCID 7764 | — |
| Reactant | 1,8-Naphthyridine | HCID 136069 | — |
| Reactant | Ethyl 2-bromo-5-methylpyridine-3-carboxylate | HCID 12919731 | — |
| Product | 4-Methoxybenzylamine | HCID 75452 | — |
| Product | Ethyl 2-bromo-5-methylpyridine-3-carboxylate | HCID 12919731 | — |
| Product | HCID 69215763 | HCID 69215763 | — |
Reaction Steps
2-Bromo-5-methyl nicotinic acid ethyl ester, depicted by formula 31 in Scheme 12, was used as a starting material to prepare compounds with methyl substitution at 6-position of naphthyridine moiety. This starting material was prepared by condensation of propionaldehyde with ethyl cyanoacetate followed by cyclisation of resulted intermediate as shown in Scheme 12. Amination of 2-bromo-5-methyl nicotinic acid ethyl ester by p-methoxy benzyl amine gave 5-methyl-2-(4-methoxy-benzylamino)-nicotinic acid ethyl ester, depicted by formula 32 in Scheme 12, which was then converted into 6-methyl-1-(4-methoxy-benzyl)-1H-pyrido[2,3-d][1,3]oxazine-2,4-dione, depicted by formula 33 in Scheme 12, by reacting with trichloromethyl chloroformate as shown in Scheme 12.
Provenance & Evidence
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|
| Patent number | US07361760B2 |
|---|
| Source dataset | uspto-grants-2008_04 |
|---|
| ORD ID | ord-dd75ed9dfc4045739451b99aacd7afec |
|---|
| Source note | uspto-grants-2008_04 |
|---|